Announcements Trials
Browse Landscape

Phase

Phase 3 12Phase 2 7Phase 2/3 4Phase 1 3Phase NA 2Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibromatosis 1 1Brain Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Methylphenidate × Clear all
NCT00576472 2017-05-30

Learning Impairments Among Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase 4 Completed
469 enrolled 43 charts
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00169611 2011-01-27

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

Hospices Civils de Lyon

Phase 4 Completed
80 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡